NCT06862245

Brief Summary

Propofol has significant hemodynamic side effects. It is a lipophilic agent and is generally used at a dose of 2-2.5 mg/kg for induction. In patients with a body mass index (BMI) greater than 25, it can lead to serious complications. This patient group often has comorbidities such as hypertension, coronary artery disease, left ventricular hypertrophy, stroke, and obstructive sleep apnea. Hemodynamic profile changes are influenced by both the rate of propofol administration and the total dose. Therefore, it is necessary to investigate the appropriate dose and infusion rate of propofol during anesthesia induction. The primary aim of this study is to compare the effects of propofol induction doses, determined based on total body weight and lean body weight (calculated using tomography), on anesthesia depth using BIS and SedLine monitoring in patients with BMI \>25. The secondary aim of the study is to compare propofol induction doses calculated using two different methods in terms of:

  • Mean arterial pressure (MAP),
  • Frequency of hypotension (MAP \<65),
  • Frequency of Trendelenburg position or vasopressor requirement and their response,
  • Tachycardia (heart rate \>100 bpm),
  • Frequency of hypertension (SBP \>140). Additionally, the sensitivity and delay rates of BIS and SedLine monitoring in determining anesthesia depth were compared. A total of 120 patients undergoing general anesthesia for urological surgeries at our hospital were included in the study. Patients were randomized into two groups (Group T/Group L). All patients were taken to the operating room, and in addition to routine monitoring, BIS and SedLine monitoring were provided. All patients received 1 mcg/kg of fentanyl.
  • Group T received propofol at a dose of 2-2.5 mg/kg based on total body weight.
  • Group L received propofol at a dose of 2-2.5 mg/kg based on lean body weight, which was calculated from CT imaging by a radiologist.
  • Propofol was administered at a rate of 100 mg/min. The laryngeal mask will be placed once an adequate depth of anesthesia is achieved. All data were recorded at 2-minute intervals for 6 minutes before and after induction. The collected data were statistically analyzed for comparison.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 2, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

19 days

First QC Date

March 2, 2025

Last Update Submit

March 7, 2025

Conditions

Keywords

lean body weightpropofol adverse reactiongeneral anaesthesia

Outcome Measures

Primary Outcomes (2)

  • anaesthesia debt based on BIS (bispectral index)

    Anesthesia depth was assessed using BIS (bispectral index) monitoring before and after induction and recorded every 2 minutes. A numeric value is recorded in the range of 0-100.

    30 minute

  • anaesthesia debt based on the SedLine value

    Anesthesia depth was assessed using SedLine monitoring before and after induction and recorded every 2 minutes. A numeric value is recorded in the range of 0-100.

    30 minute

Secondary Outcomes (4)

  • mean arterial pressure

    30 minute

  • trendelenburg

    30 minute

  • vasopressor

    30 minute

  • heart

    30 minute

Study Arms (2)

Group T

ACTIVE COMPARATOR

A total of 120 patients undergoing general anesthesia for urological surgeries at our hospital were included in the study. Patients were randomized into two groups (Group T/Group L). All patients were taken to the operating room, and in addition to routine monitoring, BIS and SedLine monitoring were provided. All patients received 1 mcg/kg of fentanyl. Group T received propofol at a dose of 2-2.5 mg/kg based on total body weight. Propofol was administered at a rate of 100 mg/min. The laryngeal mask will be placed once an adequate depth of anesthesia is achieved. All data were recorded at 2-minute intervals for 6 minutes before and after induction. The collected data were statistically analyzed for comparison.

Drug: T received propofol at a dose of 2-2.5 mg/kg based on total body weight

Group L

ACTIVE COMPARATOR

A total of 120 patients undergoing general anesthesia for urological surgeries at our hospital were included in the study. Patients were randomized into two groups (Group T/Group L). All patients were taken to the operating room, and in addition to routine monitoring, BIS and SedLine monitoring were provided. All patients received 1 mcg/kg of fentanyl. Group L received propofol at 2-2,5mg/kg dose based on lean body weight, which was calculated from CT imaging by a radiologist. Propofol was administered at a rate of 100 mg/min. The laryngeal mask will be placed once an adequate depth of anesthesia is achieved. All data were recorded at 2-minute intervals for 6 minutes before and after induction. The collected data were statistically analyzed for comparison.

Drug: Group L received propofol at 2-2,5mg/kg dose based on le

Interventions

A total of 120 patients undergoing general anesthesia for urological surgeries at our hospital were included in the study. Patients were randomized into two groups (Group T/Group L). All patients were taken to the operating room, and in addition to routine monitoring, BIS and SedLine monitoring were provided. All patients received 1 mcg/kg of fentanyl. Group T received propofol at a dose of 2-2.5 mg/kg based on total body weight. Propofol was administered at a rate of 100 mg/min. The laryngeal mask will be placed once an adequate depth of anesthesia is achieved. All data were recorded at 2-minute intervals for 6 minutes before and after induction. The collected data were statistically analyzed for comparison.

Group T

A total of 120 patients undergoing general anesthesia for urological surgeries at our hospital were included in the study. Patients were randomized into two groups (Group T/Group L). All patients were taken to the operating room, and in addition to routine monitoring, BIS and SedLine monitoring were provided. All patients received 1 mcg/kg of fentanyl. Group L received propofol at 2-2,5mg/kg dose based on lean body weight, which was calculated from CT imaging by a radiologist. Propofol was administered at a rate of 100 mg/min. The laryngeal mask will be placed once an adequate depth of anesthesia is achieved. All data were recorded at 2-minute intervals for 6 minutes before and after induction. The collected data were statistically analyzed for comparison

Group L

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A total of 120 patients of both genders,
  • Aged 18-65 years,
  • BMI \>25
  • Scheduled for elective surgery under general anesthesia in the urology operating room

You may not qualify if:

  • Patients under 18 years of age or over 65 years old
  • Patients unable to read, understand, or sign the consent form
  • Hemodynamically unstable patients
  • Patients with contraindications to anesthetic drugs
  • Patients who do not wish to participate in the study
  • Patients deemed unsuitable by the researcher
  • Patients with advanced dementia or behavioral disorders
  • Patients using psychiatric medications or abusing drugs
  • Patients requiring awake intubation
  • Emergency surgical procedures
  • Patients with more than a 5% weight change between the time of the CT scan and the surgery day
  • A time gap of more than 2 months between the CT scan and the surgery day
  • The criteria for discontinuing the study are as follows:
  • Patients who develop anaphylaxis
  • Airway failure
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Çankaya, Ankara, 06800, Turkey (Türkiye)

Location

Related Publications (4)

  • Rusch D, Arndt C, Eberhart L, Tappert S, Nageldick D, Wulf H. Bispectral index to guide induction of anesthesia: a randomized controlled study. BMC Anesthesiol. 2018 Jun 15;18(1):66. doi: 10.1186/s12871-018-0522-8.

  • Pilge S, Zanner R, Schneider G, Blum J, Kreuzer M, Kochs EF. Time delay of index calculation: analysis of cerebral state, bispectral, and narcotrend indices. Anesthesiology. 2006 Mar;104(3):488-94. doi: 10.1097/00000542-200603000-00016.

  • Gurses E, Sungurtekin H, Tomatir E, Dogan H. Assessing propofol induction of anesthesia dose using bispectral index analysis. Anesth Analg. 2004 Jan;98(1):128-131. doi: 10.1213/01.ANE.0000090314.43496.1D.

  • Schmidt GN, Bischoff P, Standl T, Lankenau G, Hilbert M, Schulte Am Esch J. Comparative evaluation of Narcotrend, Bispectral Index, and classical electroencephalographic variables during induction, maintenance, and emergence of a propofol/remifentanil anesthesia. Anesth Analg. 2004 May;98(5):1346-53, table of contents. doi: 10.1213/01.ane.0000111209.44119.30.

Study Officials

  • Seda Kurtbeyoğlu, doctor

    Ankara City Hospital Bilkent

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

March 2, 2025

First Posted

March 6, 2025

Study Start

January 1, 2025

Primary Completion

January 20, 2025

Study Completion

January 27, 2025

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations